Evidence map›Paper›PMID 30535821›Full record

ArticleJapanese journal of ophthalmology2019

In vivo histology and p.L132V mutation in KRT12 gene in Japanese patients with Meesmann corneal dystrophy.

Tsubasa Nishino, Akira Kobayashi, Natsuko Mori, Toshinori Masaki, Hideaki Yokogawa, Keiko Fujiki, Ai Yanagawa, Akira Murakami, Kazuhisa Sugiyama

Abstract read
PubMed Publisher
In one paragraph

Article in Japanese journal of ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. A Novel Pathogenic Variant in theJournal of clinical medicine · 2025
    Article
  4. Review
  5. Article
  6. Roles of the cytoskeleton in human diseases.Molecular biology reports · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tsubasa NishinoDepartment of Ophthalmology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Akira KobayashiDepartment of Ophthalmology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan. eyekoba@gmail.com.
Natsuko MoriDepartment of Ophthalmology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Toshinori MasakiDepartment of Ophthalmology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Hideaki YokogawaDepartment of Ophthalmology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Keiko FujikiDepartment of Ophthalmology, Juntendo University Graduate School of Medical Science, Tokyo, Japan.
Ai YanagawaDepartment of Ophthalmology, Juntendo University Graduate School of Medical Science, Tokyo, Japan.
Akira MurakamiDepartment of Ophthalmology, Juntendo University Graduate School of Medical Science, Tokyo, Japan.
Kazuhisa SugiyamaDepartment of Ophthalmology, Kanazawa University Graduate School of Medical Science, 13-1 Takara-machi, Kanazawa, Ishikawa, 920-8641, Japan.
Kanazawa University · JPJuntendo University · JP

Funding

Grant-in-Aid for Scientific Research (C) KAKENHI, Japan No. 16K11261
6 · The paper itself

Abstract

purposeTo report genetic mutational analysis and in vivo histology of Meesmann corneal dystrophy. STUDY

designProspective, case control study.

methodsSix patients from three independent families with clinically diagnosed Meesmann corneal dystrophy were enrolled in this study. Slit-lamp biomicroscopy with fluorescein vital staining, anterior segment optical coherence tomography (AS-OCT), and in vivo laser confocal microscopy (IVCM) were performed on selected patients. Mutational screening for the keratin genes KRT3 and KRT12 was performed in all six patients and selected unaffected family members.

resultsSlit-lamp biomicroscopy revealed numerous intraepithelial microcysts in all affected individuals. AS-OCT revealed hyperreflectivity and high corneal epithelial layer thickness (mean, 64.8μm) in all individuals tested (3/3). By using IVCM, multiple epithelial microcysts and hyperreflective materials (6/6), subepithelial nerve abnormalities (6/6), tiny punctate hyperreflective material (6/6), and needle-like hyperreflective materials (4/6) were observed in the corneal stromal layer. A heterozygous genetic mutation in the KRT12 gene (c.394 C>G, p.L132V) was identified in all six patients. No pathological mutation was observed in the KRT3 gene.

conclusionWe identified a heterozygous genetic mutation (c.394 C>G, p.L132V) in the KRT12 gene in six Japanese patients with inherited Meesmann corneal dystrophy. This is the first study to confirm this genetic mutation in Japanese Meesmann corneal dystrophy patients. This mutation has been independently reported in an American Meesmann corneal dystrophy patient, confirming its pathogenicity. AS-OCT and IVCM proved to be useful tools for observing corneal epithelial layer pathology in this dystrophy. Furthermore, IVCM reveals corneal stromal layer pathological changes not previously reported in this dystrophy.

Indexed as

MutationAdultAgedCase-Control StudiesCorneal Dystrophy, Juvenile Epithelial of MeesmannDNADNA Mutational AnalysisEpithelium, CornealExonsFemaleHeterozygoteHumansKeratin-12MaleMicroscopy, ConfocalMiddle AgedDNAKeratin-12KRT12 protein, humanAnterior segment optical coherence tomographyCorneal epitheliumGenetic mutation analysisIn vivo confocal microscopyMeesmann corneal dystrophy

Identifiers

PMID30535821
OpenAlexW2904317125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.